Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Pregabalin NDC 72888-050 by Advagen Pharma Ltd., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Pregabalin Extended-Release tablets, 165 mg - NDC 72888-050-30 - 30 Tablets Container Label - pregabalin er tab 165mg 30s label

Pregabalin Extended-Release tablets, 165 mg - NDC 72888-050-30 - 30 Tablets Container Label - pregabalin er tab 165mg 30s label

This is a medication called Pregabalin in an extended-release tablet form with a strength of 165mg. It is packaged in a child-resistant container, and a medication guide is provided separately to each patient. The medication must be stored at a temperature of 20°C to 25°C, and excursions permitted between 15°C and 30°C. This medication should only be taken as per the prescribing information. The product is distributed by Advagen Pharma Limited of Plainsboro, NJ, and manufactured by Rubicon Research Private Limited of Ambernath, India.*

Pregabalin Extended-Release tablets, 330 mg - NDC 72888-051-30 - 30 Tablets Container Label - pregabalin er tab 330mg 30s label

Pregabalin Extended-Release tablets, 330 mg - NDC 72888-051-30 - 30 Tablets Container Label - pregabalin er tab 330mg 30s label

This is a medication containing 330mg of Pregabalin, USP in extended-release tablet form. The dosage and use information is provided in the accompanying prescribing information. It should be stored in a tight, child-resistant container at a temperature between 20°C to 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (between 59°F and 86°F). The medication guide should be provided separately to each patient. This medication should be kept out of reach of children. It is distributed by Advagen Pharma Limited, located in Plainsboro, NJ, and manufactured by Rubicon Research Private Limited in India. However, no indication of the purpose of this medication is provided.*

Pregabalin Extended-Release tablets, 82.5 mg - NDC 72888-049-30 - 30 Tablets Container Label - pregabalin er tab 82pt5mg 30s labels

Pregabalin Extended-Release tablets, 82.5 mg - NDC 72888-049-30 - 30 Tablets Container Label - pregabalin er tab 82pt5mg 30s labels

This is a description of a medication containing Pregabalin, USP with a dosage of 82.5mg. Each tablet contains FD&C Yellow No.5 (tartrazine) as a color additive. The prescribing information, storage instructions, and guidelines for dispensation are also provided. This medication is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. A Medication Guide is provided separately to each patient. Further information, such as medical indications, is not available.*

Pregabalin Extended-Release tablets Equation - pregabalin er tab equation

Pregabalin Extended-Release tablets Equation - pregabalin er tab equation

This text appears to be a formula or equation related to calculating weight in kilograms using the serum creatinine levels in milligrams per deciliter (mg/dL). It also mentions a factor of 0.35 for female patients, but the context and purpose of this equation is not clear.*

Pregabalin Extended-Release tablets Figure 1 - pregabalin er tab figure1

Pregabalin Extended-Release tablets Figure 1 - pregabalin er tab figure1

Pregabalin Extended-Release tablets Structure - pregabalin er tab structure

Pregabalin Extended-Release tablets Structure - pregabalin er tab structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.